Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy

Abstract

Abstract Atherosclerosis is a typical chronic inflammatory vascular disease that seriously endangers human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used to inhibit the development of atherosclerosis. However, traditional oral drug treatments have problems such as low utilization, slow response, and serious side effects. Traditional nanodrug delivery systems are difficult to interactively recognize by normal biological organisms, and it is difficult to target the delivery of drugs to target lesions. Therefore, building a biomimetic nanodrug delivery system with targeted drug delivery based on the pathological characteristics of atherosclerosis is the key to achieving efficient and safe treatment of atherosclerosis. In this review, various nanodrug delivery systems that can target atherosclerosis are summarized and discussed. In addition, the future prospects and challenges of its clinical translation are also discussed.

Keywords

• atherosclerosis
• nano‐diagnosis
• nanoparticles
• nano‐therapy